Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open | $14.960 |
Close | $14.840 |
Volume / Avg. | 365.385K / 399.765K |
Day Range | 14.280 - 15.460 |
52 Wk Range | 4.600 - 20.900 |
Market Cap | $649.652M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 6.13% |
Days to Cover | 6.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Y-mAbs Therapeutics (NASDAQ: YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT) and Korro Bio (NASDAQ:KRRO).
The latest price target for Y-mAbs Therapeutics (NASDAQ: YMAB) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 22.00 expecting YMAB to rise to within 12 months (a possible 48.25% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $14.84 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.